ChemicalBook > CAS DataBase List > FMoc-Val-Cit-PAB-MMAE

FMoc-Val-Cit-PAB-MMAE

Product Name
FMoc-Val-Cit-PAB-MMAE
CAS No.
1350456-56-2
Chemical Name
FMoc-Val-Cit-PAB-MMAE
Synonyms
Fmoc-VC-PAB-MMAE;FMoc-Val-Cit-PAB-MMAE;Fmoc-Val-Cit-PABC-MMAE;Drug-Linker Conjugates for ADC,inhibit,FmocValCitPABMMAE,Inhibitor,Fmoc Val Cit PAB MMAE;L-Valinamide, N-[[[4-[[N-[(9H-fluoren-9-ylmethoxy)carbonyl]-L-valyl-N5-(aminocarbonyl)-L-ornithyl]amino]phenyl]methoxy]carbonyl]-N-methyl-L-valyl-N-[(1S,2R)-4-[(2S)-2-[(1R,2R)-3-[[(1R,2S)-2-hydroxy-1-methyl-2-phenylethyl]amino]-1-methoxy-2-methyl-3-oxopropyl]-1-pyrrolidinyl]-2-methoxy-1-[(1S)-1-meth...;N-[[[4-[[N-[(9H-Fluoren-9-ylmethoxy)carbonyl]-L-valyl-N5-(aminocarbonyl)-L-ornithyl]amino]phenyl]methoxy]carbonyl]-N-methyl-L-valyl-N-[(1S,2R)-4-[(2S)-2-[(1R,2R)-3-[[(1R,2S)-2-hydroxy-1-methyl-2-phenylethyl]amino]-1-methoxy-2-methyl-3-oxopropyl]-1-pyrrolidinyl]-2-methoxy-1-[(1S)-1-methylpropyl]-4-oxobutyl]-N-methyl-L-valinamide;{4-[(2S)-5-(carbamoylamino)-2-[(2S)-2-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)-3-methylbutanamido]pentanamido]phenyl}methyl N-[(1S)-1-{[(1S)-1-{[(3R,4S,5S)-1-[(2S)-2-[(1R,2R)-2-{[(1S,2R)-1-hydroxy-1-phenylpropan-2-yl]carbamoyl}-1-methoxy-2-methylethyl]pyrrolidin-1-yl]-3-methoxy-5-methyl-1-oxoheptan-4-yl](methyl)carbamoyl}-2-methylpropyl]carbamoyl}-2-methylpropyl]-N-methylcarbamate
CBNumber
CB32730902
Molecular Formula
C73H104N10O14
Formula Weight
1345.67
MOL File
1350456-56-2.mol
More
Less

FMoc-Val-Cit-PAB-MMAE Property

Boiling point:
1353.5±65.0 °C(Predicted)
Density 
1.198±0.06 g/cm3(Predicted)
pka
10.63±0.46(Predicted)
form 
Solid
color 
White to off-white
More
Less

Hazard and Precautionary Statements (GHS)

More
Less

N-Bromosuccinimide Price

ChemScene
Product number
CS-5428
Product name
Fmoc-Val-Cit-PAB-MMAE
Purity
95.05%
Packaging
1mg
Price
$420
Updated
2021/12/16
BroadPharm
Product number
BP-23246
Product name
Fmoc-Val-Cit-PAB-MMAE
Purity
98%
Packaging
10mg
Price
$890
Updated
2021/12/16
ChemScene
Product number
CS-5428
Product name
Fmoc-Val-Cit-PAB-MMAE
Purity
95.05%
Packaging
5mg
Price
$1020
Updated
2021/12/16
ChemScene
Product number
CS-5428
Product name
Fmoc-Val-Cit-PAB-MMAE
Purity
95.05%
Packaging
10mg
Price
$1620
Updated
2021/12/16
Crysdot
Product number
CD31003790
Product name
Fmoc-Val-Cit-PAB-MMAE
Purity
98+%
Packaging
5mg
Price
$589
Updated
2021/12/16
More
Less

FMoc-Val-Cit-PAB-MMAE Chemical Properties,Usage,Production

Description

Fmoc-Val-Cit-PAB-MMAE is a type of small molecule drug that can selectively target cancer cells while minimizing damage to healthy cells. The Fmoc group is a commonly used protective group in peptide synthesis and is often used to protect N-terminal amino groups. Val and Cit groups are common amino acids in peptides and proteins. The Fmoc group protects the amino group and helps to ensure that the drug is delivered intact to its target, while the Val and Cit amino acids provide a binding site for the drug to target specific cancer cells. The PAB linker (a para-aminobenzoic acid group) ensures that the MMAE cytotoxic drug is delivered specifically to cancer cells, where it can exert its toxic effects and inhibit the growth of cancer cells.

Uses

Fmoc-Val-Cit-PAB-MMAE is a precursor of antibody drug conjugate containing a cleavable Val-Cit peptide, a PABC linker and a MMAE payload. It can be attached to a monoclonal antibody (MAB) which directs it toward cancer cells.

Preparation

Fmoc-Val-Cit-PAB-PNP (388.4 mg,0.507 mmol) was dissolved in DMF (40 ml) at 0 ℃ under nitrogen protection and then HOBt (68.4 mg,0.507 mmol) and MMAE (400.0 mg,0.558 mmol) were added. After 15 min, pyridine (8 ml) and DIPEA (106.2 mL, 0.608 mmol) were added and reached 0 ℃ for 30 min. Then warmed to room temperature and stirred for 3 hours. DIPEA (106.2. mL, 0.608 mmol) was added and the reaction was continued for 24 h. After the reaction was complete, the mixture was concentrated in vacuo. The crude product was purified by column chromatography to give Fmoc-Val-Cit-PAB-MMAE as a white solid.

FMoc-Val-Cit-PAB-MMAE Preparation Products And Raw materials

Raw materials

Preparation Products

More
Less

FMoc-Val-Cit-PAB-MMAE Suppliers

SuZhou JianHua Pharmaceutical Co. Ltd
Tel
13666392288
Email
jhyylcj@163.com
Country
China
ProdList
64
Advantage
58
Shanghai Topbiochem Technology Co., Ltd
Tel
021-58170097
Email
info@topbiochem.com
Country
China
ProdList
9459
Advantage
58
Haoyuan Chemexpress Co., Ltd.
Tel
021-58950125
Fax
(86) 21-58955996
Email
info@chemexpress.com
Country
China
ProdList
7552
Advantage
61
MedChemexpress LLC
Tel
021-58955995
Fax
609-228-5909
Email
sales@medchemexpress.cn
Country
United States
ProdList
4861
Advantage
58
Tianjin Chempharmatech Co.,Ltd.
Tel
022-66211079 13212288319
Fax
qq1405432731
Email
sales@chempharmatech.com
Country
China
ProdList
864
Advantage
55
Shanghai Lollane Biological Technology Co.,Ltd.
Tel
021-52996696,15000506266 15000506266
Fax
+86-21-52996696
Country
China
ProdList
4512
Advantage
55
ALB Technology Limited
Tel
702-983-3769
Fax
702-983-3769
Email
sales@albtechnology.com
Country
United States
ProdList
2993
Advantage
55
DebyeTec.com Inc.
Tel
18086626237 18086626237
Fax
qq:2693528373
Email
sales@debyesci.com
Country
China
ProdList
2644
Advantage
56
Shanghai Changyan Chem & Tech Co., Ltd.
Tel
021-20242659 18930833303
Fax
+86 (21) 2024-2659
Email
Sales@changyanchem.cn
Country
China
ProdList
5010
Advantage
55
ShangHai Biochempartner Co.,Ltd
Tel
177-54423994 17754423994
Fax
QQ:2853530913
Email
2853530910@QQ.com
Country
China
ProdList
8011
Advantage
62
More
Less

View Lastest Price from FMoc-Val-Cit-PAB-MMAE manufacturers

Xian confluore Biological Technology Co., Ltd.
Product
Fmoc-Val-Cit-PAB-MMAE 1350456-56-2
Price
US $0.00/mg
Min. Order
250mg
Purity
>98.00%
Supply Ability
250mg
Release date
2024-03-29

1350456-56-2, FMoc-Val-Cit-PAB-MMAERelated Search:


  • FMoc-Val-Cit-PAB-MMAE
  • L-Valinamide, N-[[[4-[[N-[(9H-fluoren-9-ylmethoxy)carbonyl]-L-valyl-N5-(aminocarbonyl)-L-ornithyl]amino]phenyl]methoxy]carbonyl]-N-methyl-L-valyl-N-[(1S,2R)-4-[(2S)-2-[(1R,2R)-3-[[(1R,2S)-2-hydroxy-1-methyl-2-phenylethyl]amino]-1-methoxy-2-methyl-3-oxopropyl]-1-pyrrolidinyl]-2-methoxy-1-[(1S)-1-meth...
  • Fmoc-Val-Cit-PABC-MMAE
  • Fmoc-VC-PAB-MMAE
  • N-[[[4-[[N-[(9H-Fluoren-9-ylmethoxy)carbonyl]-L-valyl-N5-(aminocarbonyl)-L-ornithyl]amino]phenyl]methoxy]carbonyl]-N-methyl-L-valyl-N-[(1S,2R)-4-[(2S)-2-[(1R,2R)-3-[[(1R,2S)-2-hydroxy-1-methyl-2-phenylethyl]amino]-1-methoxy-2-methyl-3-oxopropyl]-1-pyrrolidinyl]-2-methoxy-1-[(1S)-1-methylpropyl]-4-oxobutyl]-N-methyl-L-valinamide
  • Drug-Linker Conjugates for ADC,inhibit,FmocValCitPABMMAE,Inhibitor,Fmoc Val Cit PAB MMAE
  • {4-[(2S)-5-(carbamoylamino)-2-[(2S)-2-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)-3-methylbutanamido]pentanamido]phenyl}methyl N-[(1S)-1-{[(1S)-1-{[(3R,4S,5S)-1-[(2S)-2-[(1R,2R)-2-{[(1S,2R)-1-hydroxy-1-phenylpropan-2-yl]carbamoyl}-1-methoxy-2-methylethyl]pyrrolidin-1-yl]-3-methoxy-5-methyl-1-oxoheptan-4-yl](methyl)carbamoyl}-2-methylpropyl]carbamoyl}-2-methylpropyl]-N-methylcarbamate
  • 1350456-56-2
  • C73H104N10O14
  • ADCs
  • ADC LINKER